Clifford Test Now Available for Patients & Practitioners Through elisa/act® biotechnologies

The Clifford Materials Reactivity Testing (CMRT) is a laboratory test that identifies existing bio-sensitivity problems in dental materials according to an individual patient’s immune system. The testing is performed with a blood sample that is drawn and prepared locally and then shipped into the lab for final analysis. The test looks at 94 chemical groups used in dental materials.

The findings of these 94 groups are compared to a database of over 17,000 dental materials to determine which materials contain and may release adversely reacting chemical groups to the specific patient. A report is then generated showing the findings of the 94 chemical groups as well as listing the trade named materials with a label listing their bio-reactivity as suited or not well suited.

Click here to see the list of items for this test.

For more information, please email or call our client services team at 800-553-5472.

ELISA/ACT Biotechnologies (EAB) is the exclusive provider of the lymphocyte response assay (LRA by ELISA/ACT) tests – the gold standard in delayed hypersensitivity testing.

Built on a strong foundation of patented technology, patient-friendly guidance, value-added support, and proven results, EAB will provide you with a successful plan to determine and address the causes of chronic disease and immune system dysfunction and restore overall health.

For over 30 years, our clinically proven, proprietary tests and individualized treatment plans have been  used successfully in managing chronic autoimmune and immune dysfunction syndromes.

We invite you learn more about:

Dr. Russell Jaffe

Russ Jaffe is Founder and Chairman of PERQUE Integrative Health, LLC, a company that offers the world scientifically proven, integrative health solutions to speed the transition from sick care to healthful caring.

Dr. Jaffe has more than 40 years of experience contributing to molecular biology and clinical diagnostics. His focus is on functional, predictive tests and procedures designed to improve the precision of both diagnosis and of treatment outcomes and he has authored nearly 100 articles on the subject.